Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-06-17$1.15/sh−7,229$8,328→ 474,473 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.